Electrophysiological evaluation of injection of tissue plasminogen activator into optic nerve

Cai-hui Jiang, Mao‐nian Zhang, Kamei Motohiro
{"title":"Electrophysiological evaluation of injection of tissue plasminogen activator into optic nerve","authors":"Cai-hui Jiang, Mao‐nian Zhang, Kamei Motohiro","doi":"10.3969/J.ISSN.1003-0808.2010.02.007","DOIUrl":null,"url":null,"abstract":"Background Retinal vein occlusion (RVO) is a common vasculoretinopathy in ophthalmology.No an effective treating way is confirmed so far,and some new approach is in exploration.Objective The present study aims to investigate the safety and feasibility of injection of tissue plasminogen activator into optic nerve for the treatment of RVO using flash visual evoked potential (F-VEP) and flash electroretinogram(F-ERG).Methods The recording electrodes for F-VEP were implanted into the skull of rabbits to investigate the safety and feasibility of injection of tPA into the optic nerve.25μg of tPA or 12.5μg tPA (0.1 mL) was injected in pars plane via the center of optical disc respectively in different groups (6 eyes in each group),and 0.1 mL of BSS was injected at the same method in control group.Other 6 eyes were as normal control group.Slit lamp biomicroscope,indirect ophthalmoscope,F-VEP and F-ERG examinations were performed in 1 day,3,4,14 and 28 days after injection.All experiments were conducted in accordance with the Association for Research in Vision and Ophthalmology statement on the use of animals in ophthalmic and Vision Research.Results No obvious evidence of optic nerve or retinal toxicity or damage was found by the examination of ophthalmoscope,F-VEP,and F-ERG after injection of tPA.No significantly differences were found in the mean latency of P_1 wave of F-VEP (P=0.411),the mean amplitude of P_1 wave of F-VEP (P=0.065),the mean latency and amplitude of ERG a-waves (P=0.627,P=0.725) as well as the mean latency and amplitude of ERG b-waves (P=0.257,P=0.096) among 25 μg of tPA group,12.5 μg tPA group,BSS group and control group.Conclusion The injection of tPA into optic nerve is a safe and simple procedure.This therapy may is a potential approach to the treatment of RVO. \n \nKey words: \ntissue plasminogen activator; optic disc; retinal vein occlusion","PeriodicalId":186994,"journal":{"name":"Chinese Ophthalmic Research","volume":"10 6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Ophthalmic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3969/J.ISSN.1003-0808.2010.02.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Retinal vein occlusion (RVO) is a common vasculoretinopathy in ophthalmology.No an effective treating way is confirmed so far,and some new approach is in exploration.Objective The present study aims to investigate the safety and feasibility of injection of tissue plasminogen activator into optic nerve for the treatment of RVO using flash visual evoked potential (F-VEP) and flash electroretinogram(F-ERG).Methods The recording electrodes for F-VEP were implanted into the skull of rabbits to investigate the safety and feasibility of injection of tPA into the optic nerve.25μg of tPA or 12.5μg tPA (0.1 mL) was injected in pars plane via the center of optical disc respectively in different groups (6 eyes in each group),and 0.1 mL of BSS was injected at the same method in control group.Other 6 eyes were as normal control group.Slit lamp biomicroscope,indirect ophthalmoscope,F-VEP and F-ERG examinations were performed in 1 day,3,4,14 and 28 days after injection.All experiments were conducted in accordance with the Association for Research in Vision and Ophthalmology statement on the use of animals in ophthalmic and Vision Research.Results No obvious evidence of optic nerve or retinal toxicity or damage was found by the examination of ophthalmoscope,F-VEP,and F-ERG after injection of tPA.No significantly differences were found in the mean latency of P_1 wave of F-VEP (P=0.411),the mean amplitude of P_1 wave of F-VEP (P=0.065),the mean latency and amplitude of ERG a-waves (P=0.627,P=0.725) as well as the mean latency and amplitude of ERG b-waves (P=0.257,P=0.096) among 25 μg of tPA group,12.5 μg tPA group,BSS group and control group.Conclusion The injection of tPA into optic nerve is a safe and simple procedure.This therapy may is a potential approach to the treatment of RVO. Key words: tissue plasminogen activator; optic disc; retinal vein occlusion
视神经注射组织型纤溶酶原激活剂的电生理评价
背景视网膜静脉闭塞(RVO)是眼科常见的血管性视网膜病变。目前还没有一种有效的治疗方法,一些新的方法正在探索中。目的探讨视神经内注射组织型纤溶酶原激活剂治疗RVO的安全性和可行性,并结合闪烁视觉诱发电位(F-VEP)和闪烁视网膜电图(F-ERG)进行观察。方法将F-VEP记录电极植入兔颅骨,探讨视神经内注射tPA的安全性和可行性。各组分别经光盘中心在视网膜平面注射25μg tPA或12.5μg tPA (0.1 mL)(每组6只眼),对照组按相同方法注射BSS 0.1 mL。其余6只眼为正常对照组。分别于注射后第1天、第3天、第4天、第14天、第28天进行裂隙灯生物显微镜、间接检眼镜及F-VEP、F-ERG检查。所有实验均按照视力和眼科研究协会关于在眼科和视力研究中使用动物的声明进行。结果tPA注射后检眼镜、F-VEP、F-ERG检查未见明显视神经、视网膜毒性或损伤。25 μg tPA组、12.5 μg tPA组、BSS组和对照组的F-VEP P_1波平均潜伏期(P=0.411)、F-VEP P_1波平均振幅(P=0.065)、ERG a波平均潜伏期和振幅(P=0.627,P=0.725)、ERG b波平均潜伏期和振幅(P=0.257,P=0.096)差异均无统计学意义。结论视神经内注射tPA是一种安全、简便的治疗方法。这种疗法可能是治疗RVO的一种潜在方法。关键词:组织型纤溶酶原激活剂;视神经盘;视网膜静脉阻塞
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信